WYNNEFIELD PARTNERS SMALL CAP VALUE LP I 13D and 13G filings for :
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-11-03 4:23 pm Purchase |
2020-11-03 | 13D | MusclePharm Corporation MSLP |
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 2,111,874 6.400% |
100,000 (+4.97%) |
Filing |
| 2020-10-28 3:57 pm Sale |
2020-10-26 | 13D | MusclePharm Corporation MSLP |
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 2,011,874 6.100% |
-31 (-0.00%) |
Filing |
| 2020-07-13 2:07 pm Purchase |
2020-07-13 | 13D | MusclePharm Corporation MSLP |
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 2,011,905 6.200% |
80,600 (+4.17%) |
Filing |